MEDIPHARM
ActiveSummary
MEDIPHARM has been active since 2003 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €336,778 and a net result of €843. Equity is growing by about 12% per year across the filed financial years. Its solvency ranks better than 71% of 22,679 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
History
Acts, filings and financial milestones
12-04
Gazette deed
Appointment: CHEAIB Samer (director)Board rule · Registered office clause · Amendment of the articles9 facts ▸
- Other provision, “mission coordination statuts, assemblée générale” (deed in French)
- Other provision, “fin fonction administrateur actuel ancien gérant, décidée à prochaine assemblée générale annuelle sur décharge exécution mandat” (deed in French)
- Board rule, 1
- Director appointment, CHEAIB Samer (director)
- Registered office clause, “1140 Evere, Allée de Provence,40” (deed in French)
- General meeting, 09-04-2024
- Amendment of the articles (2 times)
- Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in French)
- Other provision, “suppression compte de capitaux propres statutairement indisponible, supprimer” (deed in French)
About the unread acts
Of the 4 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.